RecruitingNot ApplicableNCT00912041

BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia

Sponsor

Leigh R. Hochberg, MD, PhD.

Enrollment

27 participants

Start Date

May 1, 2009

Study Type

INTERVENTIONAL

Conditions

Amyotrophic Lateral Sclerosis Spinal Cord Injuries locked-in Syndrome Muscular Dystrophy Brain Stem Infarctions tetraplegia

Summary

The purpose of this study is to obtain preliminary device safety information and demonstrate proof of principle (feasibility) of the ability of people with tetraplegia to control a computer cursor and other assistive devices with their thoughts.

Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Placement of the BrainGate2 sensor(s) into the motor-related cortex for people with amyotrophic lateral sclerosis, brain stem infarctions, and other related conditions. The study is currently recruiting participants at 6 locations. People eligible for this study include aged 18 Years to 80 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEPlacement of the BrainGate2 sensor(s) into the motor-related cortex

Up to six 4x4 mm BrainGate2 sensor(s) are placed into the motor-related cortex (including speech-related areas of cortex), connected to one, two, or three percutaneous pedestals. Neural recordings are made at least weekly for a year or more.